GAGA Share Market News

[hfe_template id='11223'] [ad_1] Brokerage firm Motilal Oswal initiated coverage on Mankind Pharma, Jefferies has a buy rating on Nykaa and Morgan Stanley recommended an overweight stance on Tata Consumer and Varun Beverages. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Motilal Oswal on Mankind Pharma: Buy| Target Rs 2650 Motilal Oswal initiated coverage on Mankind Pharma with a buy rating and a target of Rs 2,650. The company is working on multiple levers to boost growth over the next three to five years. The company is increasing the scope of business in chronic therapies. It is enhancing its presence in metro/Tier-l cities. The brokerage firm expects a 16% earnings CAGR for Mankind over FY24-27. Jefferies on NYKAA: Buy| Target Rs 220 Jefferies maintained a buy rating on NYKAA with a target price of Rs 220. The beauty and personal care segment (BPC) offers significant growth headroom.An increase in user awareness sho...

[hfe_template id='11223'] [ad_1] Benchmark equities rose on Tuesday as stock markets continued the winning march for the third straight day on the back of gains. In today's trade shares of PFC, Mankind Pharma, Patanjali Foods, Bharti Airtel, Siemens, Cipla among others will be in focus due to various news developments and quarterly results. PFC, Mankind Pharma, RVNL, Dixon, Titagarh PFC, Mankind Pharma, RVNL, Dixon and Titagarh will be in focus as the companies will announce their fourth quarter results today. Patanjali Foods Patanjali Foods posted a 22% drop in its standalone net profit at Rs 206 crore for the quarter ended March 2024, compared with Rs 264 crore in the year-ago period. Bharti Airtel Telecom major Bharti Airtel on Tuesday reported 31% fall in its consolidated net profit at Rs 2,072 crore for the quarter ended March 2024. Siemens The Board of Siemens has approved a scheme of arrangement, under which the energy business will be demerged into a separate...